http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4206142-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc04f5c89d8c275354dbd39188a766ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-18 |
| filingDate | 1978-10-06^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1980-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe2e1d0cd5ae887b40cbd9a800a0d1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac5d1a7d9982aecdcb9ee8249603868 |
| publicationDate | 1980-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4206142-A |
| titleOfInvention | Styrylamidine process |
| abstract | Styrylamidines are prepared by treating styrylsulfonylamidines with base. The styrylamidines are effective in the prevention of aggregation of blood platelets and as analgesics. Compounds of the invention are also useful as anticonvulsants, diuretics, and antihypertensive agents. The styrylsulfonylamidines of the invention which serve as precursors to the styrylamidines also have analgesic properties. Illustrative of the styrylamidines of the present invention are 4-amino-N-(4-aminostyryl)benzamidine and N-(3,4-dichlorostyryl)acetamidine. An example of a styrylsulfonylamidine is N-(styrylsulfonyl)acetamidine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5872122-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006270874-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208506-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208526-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007010564-A1 |
| priorityDate | 1973-06-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 1000 of 1319.
| Next Page | Last Page |